• Medtronic Interstim Implant for fecal incontinence

    Sacral Neuromodulation is  proven effective for chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments. A Medtronic-sponsored, prospective, multicenter trial conducted under an FDA-approved investigational protocol with 120 implanted patients demonstrated a significant improvement in fecal incontinence symptoms and quality of life.     

    For the 106 implanted patients with complete follow-up diaries at 12 months        
       41% achieved complete continence       
       83% achieved a 50% or greater reduction in incontinent episodes per week        

    Overall quality-of-life scores improved significantly from baseline, as measured by the four scales of the Fecal Incontinence Quality of Life instrument.    
  • Survey Cover letter
  • Survey for Fecal Incontinence